top of page


Viatris wins Japanese approval for Wakix in narcolepsy and obstructive sleep apnoea
Viatris has received Japanese approval for Wakix to treat narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnoea.

nuaxia
Sep 181 min read


Samsung Bioepis gains Japanese approval for intravenous Stelara biosimilar
Samsung Bioepis has received Japanese marketing approval for a 130mg intravenous formulation of its ustekinumab biosimilar referencing Stelara.

nuaxia
Sep 41 min read


Japan approves Biocon Biologics’ pegfilgrastim biosimilar for cancer supportive care
The MHLW marketing approval adds a Neulasta biosimilar to Biocon’s Japanese portfolio, with Sandoz K.K. responsible for its exclusive promotion, sale and distribution in the country.

nuaxia
Aug 252 min read
bottom of page